Efficacy and Safety of Immunosuppressive Therapy in Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis

Rosenberg, 2017, Focal segmental glomerulosclerosis, Clin J Am Soc Nephrol, 12, 502, 10.2215/CJN.05960616 De Vriese, 2018, Differentiating primary, genetic, and secondary FSGS in adults: a clinicopathologic approach, J Am Soc Nephrol, 29, 759, 10.1681/ASN.2017090958 Braun, 2008, Immunosuppressive treatment for focal segmental glomerulosclerosis in adults, Cochrane Database Syst Rev, 2008, CD003233 2021, KDIGO 2021 clinical practice guideline for the management of glomerular diseases, Kidney Int, 100, S1 Beer, 2016, Treatment strategies of adult primary focal segmental glomerulosclerosis: a systematic review focusing on the last two decades, BioMed Res Int, 2016, 10.1155/2016/4192578 Ehrich, 2007, Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated, Nephrol Dial Transplant, 22, 2183, 10.1093/ndt/gfm092 Agrawal, 2019, Loss of subpodocytic space predicts poor response to tacrolimus in steroid-resistant calcineurin inhibitor-naïve adult-onset primary focal segmental glomerulosclerosis, Indian J Nephrol, 29, 90 Raja, 2016, A prospective study of collapsing focal segmental glomerulosclerosis, Ren Fail, 38, 894, 10.3109/0886022X.2016.1164063 Singh, 1999, One-center experience with cyclosporine in refractory nephrotic syndrome in children, Pediatr Nephrol, 13, 26, 10.1007/s004670050557 Mahmoud, 2005, Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis, Nephrol Dial Transplant, 20, 735, 10.1093/ndt/gfh766 Huang, 2018, Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria, Clin Exp Nephrol, 22, 1315, 10.1007/s10157-018-1585-z Chishti, 2001, Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose, Am J Kidney Dis, 38, 754, 10.1053/ajkd.2001.27692 Cattran, 2003, Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosis, J Am Soc Nephrol, 14, 448, 10.1097/01.ASN.0000046960.57614.17 Senthil Nayagam, 2008, Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study, Nephrol Dial Transplant, 23, 1926, 10.1093/ndt/gfm538 Loeffler, 2004, Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome, Pediatr Nephrol, 19, 281, 10.1007/s00467-003-1370-3 Arias, 2011, Tip variant of focal segmental glomerulosclerosis: outcome and comparison to “not otherwise specified” variant, Nephrol Dial Transplant, 26, 2215, 10.1093/ndt/gfq668 Gorsane, 2016, Cyclosporine therapy in steroid-dependent or steroid-resistant idiopathic focal and segmental glomerulosclerosis, Saudi J Kidney Dis Transpl, 27, 958, 10.4103/1319-2442.190864 Hari, 2001, Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide, Pediatr Nephrol, 16, 901, 10.1007/s004670100680 Abeyagunawardena, 2007, Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis, Pediatr Nephrol, 22, 215, 10.1007/s00467-006-0264-6 Abrantes, 2006, Predictive factors of chronic kidney disease in primary focal segmental glomerulosclerosis, Pediatr Nephrol, 21, 1003, 10.1007/s00467-006-0138-y Abrantes, 2006, Clinical course of 110 children and adolescents with primary focal segmental glomerulosclerosis, Pediatr Nephrol, 21, 482, 10.1007/s00467-006-0019-4 Adhikari, 1997, Intensive pulse therapies for focal glomerulosclerosis in South African children, Pediatr Nephrol, 11, 423, 10.1007/s004670050309 Adhikari, 2001, Focal segmental glomerulosclerosis in children from KwaZulu/Natal, South Africa, Clin Nephrol, 55, 16 Agarwal, 1993, Idiopathic adult focal segmental glomerulosclerosis: a clinicopathological study and response to steroid, Nephron, 63, 168, 10.1159/000187177 Al Salloum, 2004, Pulse cyclophosphamide therapy for steroid-resistant focal segmental glomerulosclerosis in children, Ann Saudi Med, 24, 27, 10.5144/0256-4947.2004.27 Alexopoulos, 2000, Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis, Nephrol Dial Transplant, 15, 1348, 10.1093/ndt/15.9.1348 Arbus, 1982, Focal segmental glomerulosclerosis with idiopathic nephrotic syndrome: three types of clinical response, J Pediatr, 101, 40, 10.1016/S0022-3476(82)80177-7 Ayar, 2016, Can FE. Primary glomerulonephritis: a single-center retrospective experience, Acta Med Mediterr, 32, 1723 Bagchi, 2016, Primary FSGS in nephrotic adults: clinical profile, response to immunosuppression and outcome, Nephron, 132, 81, 10.1159/000442999 Beşbaş, 2010, Clinical course of primary focal segmental glomerulosclerosis (FSGS) in Turkish children: a report from the Turkish Pediatric Nephrology FSGS Study Group, Turk J Pediatr, 52, 255 Bhimma, 2006, Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus, Am J Nephrol, 26, 544, 10.1159/000097864 Brodehl, 1988, Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis, Klin Wochenschr, 66, 1126, 10.1007/BF01727848 Cattran, 1998, Long-term outcome in children and adults with classic focal segmental glomerulosclerosis, Am J Kidney Dis, 32, 72, 10.1053/ajkd.1998.v32.pm9669427 Cattran, 1999, A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group, Kidney Int, 56, 2220, 10.1046/j.1523-1755.1999.00778.x Cattran, 2004, Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis, Clin Nephrol, 62, 405, 10.5414/CNP62405 Chávez-Mendoza, 2019, Calcineurin inhibitors with reduced-dose steroids as first-line therapy for focal segmental glomerulosclerosis, Kidney Int Rep, 4, 40, 10.1016/j.ekir.2018.08.010 Choi, 2002, Mycophenolate mofetil treatment for primary glomerular diseases, Kidney Int, 61, 1098, 10.1046/j.1523-1755.2002.00214.x Chun, 2004, Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants, J Am Soc Nephrol, 15, 2169, 10.1097/01.ASN.0000135051.62500.97 Crook, 2005, Effects of steroids in focal segmental glomerulosclerosis in a predominantly African-American population, Am J Med Sci, 330, 19, 10.1097/00000441-200507000-00004 Dumas De La Roque, 2018, Idiopathic nephrotic syndrome: characteristics and identification of prognostic factors, J Clin Med, 7, 265 Deegens, 2005, Idiopathic focal segmental glomerulosclerosis: a favourable prognosis in untreated patients?, Neth J Med, 63, 393 Deegens, 2008, Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population–epidemiology and outcome, Nephrol Dial Transplant, 23, 186, 10.1093/ndt/gfm523 Dhanapriya, 2016, Clinicopathological correlation and treatment response of primary focal segmental glomerulosclerosis in adults and adolescents, Indian J Nephrol, 26, 347, 10.4103/0971-4065.167283 Dimkovic, 2009, Mycophenolate mofetil in high-risk patients with primary glomerulonephritis: results of a 1-year prospective study, Nephron Clin Pract, 111, c189, 10.1159/000199459 El-Husseini, 2004, Effect of concomitant administration of cyclosporine and ketoconazole in children with focal segmental glomerulosclerosis, Am J Nephrol, 24, 301, 10.1159/000078395 El-Refaey, 2007, Idiopathic collapsing focal segmental glomerulosclerosis in pediatric patients, Pediatr Nephrol, 22, 396, 10.1007/s00467-006-0312-2 El-Refaey, 2010, Primary focal segmental glomerulosclerosis in Egyptian children: a 10-year single-centre experience, Pediatr Nephrol, 25, 1369, 10.1007/s00467-010-1448-7 Futrakul, 2004, Hemodynamic maladjustment and disease progression in nephrosis with FSGS, Ren Fail, 26, 231, 10.1081/JDI-120039520 Futrakul, 2004, Correction of peritubular capillary flow reduction with vasodilators restores function in focal segmental glomerulosclerotic nephrosis, Clin Hemorheol Microcirc, 31, 197 Gellermann, 2012, Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome, Nephrol Dial Transplant, 27, 1970, 10.1093/ndt/gfr572 Gheissari, 2018, TRPC6 mutational analysis in Iranian children with focal segmental glomerulosclerosis, Iran J Kidney Dis, 12, 341 Ghiggeri, 2004, Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study, Clin Ther, 26, 1411, 10.1016/j.clinthera.2004.09.012 Gipson, 2011, Clinical trial of focal segmental glomerulosclerosis in children and young adults, Kidney Int, 80, 868, 10.1038/ki.2011.195 Goumenos, 2006, Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study, Nephron Clin Pract, 104, c75, 10.1159/000093993 Greenwood, 2017, Clinical presentation, treatment and outcome of focal segmental glomerulosclerosis in Far North Queensland Australian adults, Nephrology (Carlton), 22, 520, 10.1111/nep.12816 Gulati, 2000, Early versus late-onset idiopathic focal segmental glomerulosclerosis, Pediatr Nephrol, 14, 960, 10.1007/PL00013419 Heering, 2004, Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis, Am J Kidney Dis, 43, 10, 10.1053/j.ajkd.2003.09.027 Hogg, 2013, Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS, Clin J Am Soc Nephrol, 8, 211, 10.2215/CJN.08330812 Hoseini, 2012, Prevalence and outcome of focal segmental glomerulosclerosis in Iranian children with nephrotic syndrome, Iran J Kidney Dis, 6, 18 Inaba, 2016, Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children, Pediatr Nephrol, 31, 425, 10.1007/s00467-015-3174-7 Ingulli, 1995, Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis, J Am Soc Nephrol, 5, 1820, 10.1681/ASN.V5101820 Jafry, 2012, Raised serum creatinine at presentation does not adversely affect steroid response in primary focal segmental glomerulosclerosis in adults, Nephrol Dial Transplant, 27, 1101, 10.1093/ndt/gfr430 Jellouli, 2016, Focal segmental glomerulosclerosis in children, Tunis Med, 94, 356 Kallash, 2014, Efficacy of tacrolimus in the treatment of children with focal segmental glomerulosclerosis, World J Pediatr, 10, 151, 10.1007/s12519-014-0484-y Kambham, 2001, Obesity-related glomerulopathy: an emerging epidemic, Kidney Int, 59, 1498, 10.1046/j.1523-1755.2001.0590041498.x Kangovi, 2012, Renin-angiotensin-aldosterone system inhibitors in pediatric focal segmental glomerulosclerosis, Pediatr Nephrol, 27, 813, 10.1007/s00467-011-2056-x Kirpekar, 2002, Clinicopathologic correlates predict the outcome in children with steroid-resistant idiopathic nephrotic syndrome treated with pulse methylprednisolone therapy, Am J Kidney Dis, 39, 1143, 10.1053/ajkd.2002.33382 Klaassen, 2015, Response to cyclosporine in steroid-resistant nephrotic syndrome: discontinuation is possible, Pediatr Nephrol, 30, 1477, 10.1007/s00467-015-3109-3 Korbet, 1986, The prognosis of focal segmental glomerular sclerosis of adulthood, Medicine, 65, 304, 10.1097/00005792-198609000-00003 Laurin, 2016, Renal survival in patients with collapsing compared with not otherwise specified FSGS, Clin J Am Soc Nephrol, 11, 1752, 10.2215/CJN.13091215 Laurin, 2016, Treatment with glucocorticoids or calcineurin inhibitors in primary FSGS, Clin J Am Soc Nephrol, 11, 386, 10.2215/CJN.07110615 Li, 2014, Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS, Clin J Am Soc Nephrol, 9, 1903, 10.2215/CJN.02370314 Lieberman, 1996, A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children, J Am Soc Nephrol, 7, 56, 10.1681/ASN.V7156 Martinelli, 2001, Primary focal segmental glomerulosclerosis in children: prognostic factors, Pediatr Nephrol, 16, 658, 10.1007/s004670100639 Martinelli, 2004, Cyclophosphamide in the treatment of focal segmental glomerulosclerosis, Braz J Med Biol Res, 37, 1365, 10.1590/S0100-879X2004000900011 Mendoza, 1990, Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents, Pediatr Nephrol, 4, 303, 10.1007/BF00862503 Meyrier, 1994, Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie, Kidney Int, 45, 1446, 10.1038/ki.1994.189 Mubarak, 2010, Collapsing FSGS: a clinicopathologic study of 10 cases from Pakistan, Clin Exp Nephrol, 14, 222, 10.1007/s10157-010-0275-2 Mungan, 2015, Tip lesion variant of primary focal and segmental glomerulosclerosis: clinicopathological analysis of 20 cases, Ren Fail, 37, 858, 10.3109/0886022X.2015.1033635 Naseri, 2009, Correlation between prognosis and response to treatment in children with FSGS, Acta Med Iran, 47, 93 Newman, 1976, Focal glomerular sclerosis: contrasting clinical patterns in children and adults, Medicine, 55, 67, 10.1097/00005792-197601000-00004 Niaudet, 1994, Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. French Society of Pediatric Nephrology, J Pediatr, 125, 981, 10.1016/S0022-3476(05)82020-7 Paik, 2007, Primary focal segmental glomerular sclerosis in children: clinical course and prognosis, Pediatr Nephrol, 22, 389, 10.1007/s00467-006-0301-5 Pei, 1987, Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study, Am J Med, 82, 938, 10.1016/0002-9343(87)90155-0 Ponticelli, 1999, Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?, Am J Kidney Dis, 34, 618, 10.1016/S0272-6386(99)70384-7 Ramachandran, 2014, Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience, Nephrol Dial Transplant, 29, 1918, 10.1093/ndt/gfu097 Ren, 2013, Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial, Am J Nephrol, 37, 84, 10.1159/000346256 Rennert, 1999, Pulse cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis, Pediatr Nephrol, 13, 113, 10.1007/s004670050574 Risler, 1996, The German Glomerulonephritis Therapy Study: 10 years of controlled randomized trials for the treatment of idiopathic glomerulonephritis, Kidney Blood Press Res, 19, 196, 10.1159/000174073 Roberti, 2010, Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus, Pediatr Nephrol, 25, 1117, 10.1007/s00467-010-1471-8 Rydel, 1995, Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment, Am J Kidney Dis, 25, 534, 10.1016/0272-6386(95)90120-5 Schwartz, 1999, Focal segmental glomerulosclerosis: prognostic implications of the cellular lesion, J Am Soc Nephrol, 10, 1900, 10.1681/ASN.V1091900 Segarra, 2002, Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up, Nephrol Dial Transplant, 17, 655, 10.1093/ndt/17.4.655 Segarra, 2007, Efficacy and safety of “rescue therapy” with mycophenolate mofetil in resistant primary glomerulonephritis–a multicenter study, Nephrol Dial Transplant, 22, 1351, 10.1093/ndt/gfl805 Segarra Medrano, 2011, Efficacy and safety of combined cyclosporin A and mycophenolate mofetil therapy in patients with cyclosporin-resistant focal segmental glomerulosclerosis, Nefrologia, 31, 286 Shatat, 2007, Association of steroid and cyclosporin resistance in focal segmental glomerulosclerosis, Pediatr Nephrol, 22, 834, 10.1007/s00467-006-0413-y Sherali, 2010, Response to cyclosporin in children with primary focal segmental glomerulosclerosis, Pak Pediatr J, 34, 10 Silverstein, 2007, Presenting features and short-term outcome according to pathologic variant in childhood primary focal segmental glomerulosclerosis, Clin J Am Soc Nephrol, 2, 700, 10.2215/CJN.00230107 Stirling, 2005, Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units, QJM, 98, 443, 10.1093/qjmed/hci072 Tarshish, 1996, Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children, Pediatr Nephrol, 10, 590, 10.1007/s004670050167 Troyanov, 2005, Toronto Glomerulonephritis Registry Group. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission, J Am Soc Nephrol, 16, 1061, 10.1681/ASN.2004070593 Wasilewska, 2004, Transforming growth factor-beta1 in nephrotic syndrome treated with cyclosporine and ACE inhibitors, Pediatr Nephrol, 19, 1349, 10.1007/s00467-004-1619-5 Zagury, 2013, Steroid-resistant idiopathic nephrotic syndrome in children: long-term follow-up and risk factors for end-stage renal disease, J Bras Nefrol, 35, 191, 10.5935/0101-2800.20130031 Nankivell, 2001, Abnormal laboratory results: cCreatinine clearance and the assessment of renal function, Aust Prescr, 24, 15, 10.18773/austprescr.2001.009 De Vriese, 2021, Therapeutic trials in adult FSGS: lessons learned and the road forward, Nat Rev Nephrol, 17, 619, 10.1038/s41581-021-00427-1